The Food and Drug Administration (FDA) has approved Miudella ® (copper intrauterine system [IUS]) for the prevention of pregnancy in females of reproductive potential for up to 3 years.

Intrauterine devices (IUDs) are an extremely effective method of birth control. An IUD is a small, T-shaped device that’s placed in your uterus. It must be prescribed by a doctor, who will place ...

According to the Centers for Disease Control and Prevention (CDC), copper IUDs have a failure rate of 0.8%, while the levonorgestrel intrauterine system has a failure rate of 0.1 to 0.4%.

ROSWELL, Ga., Feb. 25, 2025 /PRNewswire/ -- Sebela Women's Health Inc., a part of Sebela Pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) granted approval of ...

Experts said the risks were still very low, but it was important for women to be fully informed when considering their contraceptive choices ...

Depot medroxyprogesterone acetate initiated at 6 weeks postpartum* Hormonal implants inserted at 6 weeks postpartum* The levonorgestrel intrauterine system can be inserted at 6 weeks postpartum.

[29] Other medical alternatives are the Levonorgestrel-releasing intrauterine system (LNG-IUS) and GnRH-agonists. However, the LNG-IUS cannot be applied in case of significant distortion of the ...

The company's first product, the Juveena Hydrogel System, is designed for preventing the formation or reformation of intrauterine adhesions following transcervical gynecological procedures.